A Five-Gene Expression Signature Predicts Clinical Outcome of Ovarian Serous Cystadenocarcinoma

Table 1

Assignment of patient demographic and clinical characteristics.

Characteristic	Patients
	Training set	Testing set	Total
Age at diagnosis (years)
Median	57	59	58
Range	34–87	30–87	30–87
Vital status
Living	58	62	120
Dead	110	73	183
Follow-up (days)
Median	1018	883	949
Median (dead)	1155	919	1069
Clinical stage
Stage I	0	1	1
Stage II	8	13	21
Stage III	142	99	241
Stage IV	18	20	38
Unknown	0	2	2